ABSTRACT RESUMEN ARTICLE YOUSSFI-RICH A 1, CLEMENT-FERNÁNDEZ F 2, GARCÍA-URTUETA E 2, CLEMENT-CORRAL A 1

Similar documents
Stabilization of visual acuity with photodynamic therapy in eyes with chorioretinal anastomoses

FEEDER VESSEL TREATMENT

The Natural History of Occult Choroidal Neovascularisation Associated With Age-related Macular Degeneration. A Systematic Review

Photodynamic Therapy for Treatment of Subfoveal Choroidal Neovascularization in Exudative Age-Related Macular Degeneration

Department of Ophthalmology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea

연령연관황반변성에서망막혈관종성증식과동반된망막색소상피박리의임상양상과일차적인광역학치료의결과

ZEISS AngioPlex OCT Angiography. Clinical Case Reports

AGE-RELATED MACULAR DEGENERATION IS THE LEADing

Fluorescein Angiography

I n the Western world, age related macular degeneration

The limited number of currently approved

Despite our growing knowledge of the

Michael P. Blair, MD Retina Consultants, Ltd Libertyville/Des Plaines, Illinois Clinical Associate University of Chicago 17 October 2015

Clinical Policy Title: Ocular photodynamic therapy (OPDT) with Visudyne (verteporfin) for macular degeneration treatment

Clinical Trials Related to Age Related Macular Degeneration

Therapeutic Effect of Diode Laser Photodynamic Therapy with ICG Dye in ARMD: A Case Report

Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin

CENTRAL SEROUS CHORIORETINOPATHY (CSC) IS

R&M Solutions

VERTEPORFIN IN PHOTODYNAMIC THERAPY STUDY GROUP

Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularisation

Clinical Study Choroidal Thickness in Eyes with Unilateral Ocular Ischemic Syndrome

Case Report: Indocyanine Green Dye Leakage from Retinal Artery in Branch Retinal Vein Occlusion

CLINICAL SCIENCES. Verteporfin Therapy for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration

Subgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration

CLINICAL SCIENCES. Treatment of Retinal Angiomatous Proliferation in Age-Related Macular Degeneration

SUMMARY. Heather Casparis, MD,* and Neil M. Bressler, MD MARINA AND ANCHOR

Description. Section: Other Effective Date: July 15, Subsection: Vision Original Policy Date: December 7, 2011 Subject: Page: 1 of 23

Photodynamic Therapy for Choroidal Neovascularization

IQ 532 Micropulse Green Laser treatment for Refractory Chronic Central Serous Retinopathy

International Journal of Health Sciences and Research ISSN:

SHORT COMMUNICATION. and development of visual acuity. Methods: We have retrospectively

OCT Angiography in Primary Eye Care

Original Policy Date

FEP Medical Policy Manual

Corinne GONZALEZ Ophthalmology (MD, Ph.D ) Retinal Medical Specialist

CLINICAL SCIENCES. Visual Outcomes Following Macular Translocation With 360 Peripheral Retinectomy

Current indications for photodynamic therapy in medical retina practice

Retina Conference. Janelle Fassbender, MD, PhD University of Louisville Department of Ophthalmology and Visual Sciences 09/04/2014

COMPLICATIONS OF UVEITIS: PREVALENCE AND RISK FACTORS IN A SERIE OF 398 CASES

Myopic Choroidal Neovascularization


A Comparative Study of Age Related Macular Degeneration In Relation To SD-OCTand Fundus Photography.

DOME SHAPED MACULOPATHY. Ιωάννης Ν. Βαγγελόπουλος Χειρ. Οφθαλμίατρος - Βόλος

Clinically Significant Macular Edema (CSME)

The legally binding text is the original French version

Diabetes mellitus: A risk factor affecting visual outcome in branch retinal vein occlusion

Indocyanine Green Angiography Findings in Central Serous Chorioretinopathy

MONTHLY ADMINISTERED INTRAVITREOUS PHARmacotherapy

Principal Investigator: Mårten Brelen, Assistant Professor Department of Ophthalmology & Visual Sciences (DOVS), CUHK

CMS Manual System Pub Medicare National Coverage Determinations

Common Causes of Vision Loss

Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration.

MEDICAL POLICY SUBJECT: PHOTODYNAMIC THERAPY FOR EFFECTIVE DATE: 07/20/00 SUBFOVEAL CHOROIDAL NEOVASCULARIZATION

Since /01/2014 Private practice Ophthalmology, Retinal Medical Specialty and AMD, private office

Oishi A, Miyamoto K, Yoshimura N. Etiology of carotid cavernous fistula in Japanese. Jpn J Ophthalmol. 2009;53:40-43.

QUALITY OF LIFE IN PATIENTS WITH CHOROIDAL MELANOMA

Ophthalmology Macular Pathways

Abstract Aims To analyse the histopathology of classic and occult choroidal neovascular membrane surgical specimens in age

A prospective nonrandomized clinical study on exudative age related macular degeneration

Mitsuko Yuzawa,* Takako Isomae,* Ryuzaburo Mori,* Hiroyuki Shimada* and Izumi Utsunomiya

Efficacy of Anti-VEGF Agents in the Treatment of Age-Related Macular Degeneration

Photodynamic therapy. in the treatment of subfoveal choroidal neovascu larisation

Retinal Pigment Epithelial Tears (Rips) in the ERA of Anti Vegf - When and Why?

OCT Angiography The Next Frontier

Photocoagulation of disciform macular lesions

THE OCULAR histoplasmosis

Long-term Management of AMD. Motasem Al-latayfeh, MD Assistant Prof. Ophthalmology Hashemite University Jordan

NEOVASCULAR AGE-RELATED MACULAR DEGENERation

Risk factors of a reduced response to ranibizumab treatment for neovascular age-related macular degeneration evaluation in a clinical setting

THE ROLE OF anti-vegf IN DIABETIC RETINOPATHY AND AGE RELATED MACULAR DEGENERATION

You can see clearly now. Heidelberg Retina Angiograph 2

HHS Public Access Author manuscript Ophthalmic Surg Lasers Imaging Retina. Author manuscript; available in PMC 2016 January 14.

STUDY OF THE RETINAL NERVE FIBER LAYER IN CHILDHOOD STRABISMUS

Posterior Vitreomacular Adhesion and Risk of Exudative Age-related Macular Degeneration : Paired Eye Study

Fluorescein Angiography Compared to Three-Dimensional Measurements by the Retinal Thickness Analyzer in Classic Choroidal Neovascularization

Study of clinical significance of optical coherence tomography in diagnosis & management of diabetic macular edema

Clinical Policy: Neovascular (WET) Macular Degeneration Treatment Reference Number: CP.MP.283

RETINAL TOXICITY FOLLOWING CHLOROQUINE THERAPY

Retinal Pigment Epithelial Detachment

Retinal Nerve Fiber Layer Measurements in Myopia Using Optical Coherence Tomography

A retrospective nonrandomized study was conducted at 3

Fluorescein and Indocyanine Green Videoangiography of Choroidal Melanomas

Digital Journal of Ophthalmology Digital Journal of Ophthalmology. Abstract

HIGH DOSE TISSUE PLASMINOGEN ACTIVATOR (TPA) (100 MCG/0.1 ML) AND C3F8 GAS IN PNEUMATIC DISPLACEMENT OF SUBMACULAR

CASE STUDIES CURRENT AND FUTURE TREATMENT OPTIONS FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION * Discussion led by Neil M.

Choroidal neovascularization in a young, healthy eye after LASIK

A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration

Age-related Macular Degeneration Update

THE OPHTHALMOLOGIST S NEEDS FOR THE ANALYSIS OF THE RETINA

OCT Assessment of the Vitreoretinal Relationship in CSME

Intravitreal ranibizumab and bevacizumab for the treatment of nonsubfoveal choroidal neovascularization in age-related macular degeneration

I diopathic central serous (chorio)retinopathy (CSR) is a

Spontaneous Large Serous Retinal Pigment Epithelial Tear

Treatment of diabetic maculopathy by

Preliminary report on effect of retinal panphotocoagulation on rubeosis iridis and

CLINICAL SCIENCES. Laser Burn Intensity and the Risk for Choroidal Neovascularization in the CNVPT Fellow Eye Study

CLINICAL SCIENCES. Photodynamic Therapy With Verteporfin. Observations on the Introduction of a New Treatment Into Clinical Practice

Intraocular Radiation Therapy for Age-Related Macular Degeneration

Transcription:

ARCH SOC ESP OFTALMOL 2006; 81: 79-84 ARTICLE FEEDER VESSEL DETECTION BY MEANS OF DYNAMIC INDOCYANINE GREEN ANGIOGRAPHY OF SUBFOVEAL CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION ANGIOGRAFÍA DINÁMICA CON VERDE INDOCIANINA EN EL DIAGNÓSTICO DE VASOS NUTRICIOS DE COMPLEJOS NEOVASCULARES SUBFOVEALES COROIDEOS EN LA DEGENERACIÓN MACULAR ASOCIADA A LA EDAD YOUSSFI-RICH A 1, CLEMENT-FERNÁNDEZ F 2, GARCÍA-URTUETA E 2, CLEMENT-CORRAL A 1 ABSTRACT Purpose: This study aimed to assess the detection and characteristics of feeder vessels (FV) of subfoveal choroidal neovascularization (CNV) in agerelated macular degeneration (ARMD). Methods: A retrospective study of 59 consecutive eyes presenting subfoveal CNV secondary to ARMD was performed. Feeder vessels were detected by means of indocyanine green video angiography using a confocal scanning laser ophthalmoscope. The following factors were analyzed: patient age, visual acuity using Snellen lines and/or ETDRS, fluorescein angiographic (FA) patterns, size of CNV, and time of evolution. The following characteristics of FV also were evaluated: FV pattern (umbrella or racquet-like pattern), number, width and the location with respect to the fovea. Results: FV were detected in 36 subfoveal CNV (61%). No significant differences were noted between the presence of FV in terms of visual acuity (U Mann-Whitney, p=0.816), FA patterns (Fisher s RESUMEN Objetivo: Detectar y caracterizar los vasos nutricios (VNA) de las membranas neovasculares (NVC) subfoveales en la degeneración macular asociada a la edad (DMAE). Métodos: Estudio retrospectivo en 59 ojos consecutivos con NVC subfoveal secundaria a DMAE. Los VNA fueron detectados gracias a la videoangiografía verde-indocianina, con un oftalmoscopio láser confocal de barrido. Se analizaron los factores siguientes: edad, AV con los optotipos de Snellen y/o ETDRS, patrón de la AFG, tamaño de la NVC y tiempo de evolución. En los VNA se estudió el patrón angiográfico, en paraguas o en raqueta, el número, grosor y localización con respecto a la fóvea. Resultados: Se detectaron VNA en 36 NVC subfoveales (61%). No se encontraron diferencias significativas entre la presencia de vaso nutricio y la AV (U Mann Whitney, p=0,816), el patrón de la AFG (fisher test, p=0,265), el tamaño de la NVC (U Received: 31/5/05. Accepted: 20/2/06. Clínica de La Paloma. Clínica Clement Madrid. Spain. 1 PhD. in Medicine. 2 Doctor in Medicina. Communication presented at the LXXVIII Congress of the (Murcia 2002). Correspondence: Youssfi-Rich A Clínica Clement C/. Fuencarral, 96 28004 Madrid Spain E-mail: hakimyoussfi@mac.com

YOUSSFI-RICH A, et al. exact probability test p=0.265), size of the CNV (U Mann-Whitney, p=0.267) and time of evolution (U Mann-Whitney, p=0.099). The most common pattern FV was a the racquet-like pattern, inserted in the subfoveal CNV from an extrafoveal origin on the nasal side after a variable course of approximately 1.27 mm (range 0.1-2.9 mm), with a diameter of 83.3 µm (range 20-150 µm). Conclusions: FV were detected in 36 subfoveal CNV (61%) in ARMD. Only 16 subfoveal CNV (25.4%) were considered eligible for FV treatment (Arch Soc Esp Oftalmol 2006; 81: 79-84). Key words: Feeder vessels, CNV, ARMD. INTRODUCTION Age related macular degeneration (ARMD) is the most frequent cause of legal blindness in patients over 65 in developed countries (1). the presence of a coroidal neovascular complex (CNV) is less frequent but it produces faster and more severe loss of vision than the atrophic form. Direct photo-coagulation of the entire CNV is efficient but only allows an acceptable functional result in the extra-foveal forms, while photo-dynamic therapy achieves permanent closure of the membrane but produces poor functional results (2). Even though macular translocation of CNVs produces satisfactory functional results in selected cases, it presents a very high percentage of severe complications (3). In recent years different groups have demonstrated the possibility of locating the afferent feeder vessels (ANV) of the CNV utilizing videoangiography with indocyanine green (ICG) and, after direct photocoagulation of said vessels, the closure of the neovascular membrane (4,5). The purpose of this study is to evaluate the detection capacity of ANVs in sub-foveal CNVs by means of high-speed ICG videoangiography as well as to analyze the characteristics of ANVs in what concerns the behavior of sub-foveal CNVs and the possibility of photocoagulation thereof. SUBJECTS, MATERIAL AND METHODS Fifty-nine videoangiographies of exudative ARMD due to CNV were taken from 53 consecutive patients from July 2000 to August 2002. Mann Whitney, p=0,267), o el tiempo de evolución (U Mann Whitney, p=0,099). El patrón de la AFG más común fue el tipo raqueta, con nacimiento nasal extrafoveal, con un recorrido medio de 1,27 mm (rango 0,1-2,9) y un diámetro medio de 83,3 µm (rango 20-150). Conclusiones: Se pudo identificar VNA en el 61% de una población con NVC bien o mal delimitadas, y solo 16 NVC subfoveales (25,4%) reunieron las características necesarias para realizar tratamiento con láser del VNA. Palabras clave: Vasos nutricios, NVC, DMAE. After signing the informed consent form, all patients took a complete ophthalmologic exploration, including visual acuity with Snellen equivalent (ETDRS and/or Snellen), funduscopy, retinography (CANON CF-60, Canon Inc. USA), fluorescein angiography (AGF) (Canon CF-60 or Heidelberg Retina Tomograph, HRT), and dynamic ICG. The latter was made injecting 2.5 ml of an indocyanine green 10% solution (ICG-pulsion, Pulsion Medical System) in the cubital vein followed by 5ml of saline solution. Recordings with the HRT were initiated 4 seconds after the injection of the dye and were maintained for 15 seconds. The ICG videoangiography obtained comprised 12 images per second with a resolution of 512 x 512 pixels and a fields of 20º to 30º and photographs at 15, 30, 60 seconds, 5 and 15 minutes from the test. We excluded the cases with poor quality of the angiographic study due to lack of cooperation or blurry medium, as well as the cases with vascularized serous detachment or severe hemorrhage hiding the membrane. The recordings were assessed by two retinologists (EGU, FCC) experienced in HRT videoangiography. The MPS (6) classification was utilized to separate CNS as classical and hidden type 1, with fibrovascular detachment and type 2, with late ooze of the dye due to non-determined causes. The membranes were subdivided in three groups according to the evolution time (under 6 months, between 6 months and one year, and over one year) and according to size (under 5 mm 2, between 5 and 15 mm2, and over 15 mm 2 ). We determined the presence or absence of ANV(s), the location with respect to the fovea, the length of the main trunk (considering it from the 80 ARCH SOC ESP OFTALMOL 2006; 81: 79-84

Diagnóstico de vasos nutricios de complejos neovasculares subfoveales coroideos beginning of the vessel up to the first bifurcation) and its diameter. The type of ANV was classified according to the neovascular pattern described by Staurenghi (5), in racquet (R) when the main trunk appeared in the plane of the membrane (fig. 1), and in umbrella shape (P) when the ANV began below the CNV (fig. 2), showing the section of the main trunk. The measures were made utilizing the HRT software. The presence of ANV was correlated to the type of neovascular membrane by means of Fisher s exact test, while the Mann-Whitney test allowed us to analyze the presence or absence of ANV as regards the evolution time, the membrane size and visual acuity. Statistical tests were made with the SPSS (Statistical Package for the Social Sciences, SYSTAT software, version 11 for Macintosh). RESULTS Population characteristics The study included 34 women and 19 men, mean age 72.4, SD 9.8 and a range between 50 and 91 years of age. Forty-seven patients exhibited a unilateral subfoveal CNV membrane while 6 were bilateral. Of the 59 eyes, 54.4% had visual acuity below 0.16, with the mean being 0.21 SD 0.91 in Snellen Fig. 2: Subfoveal neovascular membranes with umbrella pattern. equivalent. 38.2% of patients had a history of arterial high pressure or cardiovascular disease. Characteristics of the membranes The classic form was described in eight cases (13.6%), the mixed form in six (10.1%) and 45 patients (76.3%) exhibited hidden CNV, of which 32 were of type 1 (54.2%) and 13 of type 2 (22%). The mean size was under 5 mm 2 in 12 patients (20.4%), 23 had a membrane between 5 and 15 mm 2 (39%), and a further 24 over 15 mm 2 (40.6%). The evolution time was under 6 months in 29 patients (49.1%), between 6 months and one year in 12 cases (20.4%), and over one year in 18 cases (30.5%). Characteristics of the ANVs Fig. 1: Subfoveal neovascular membrane with racquet pattern. Identification of the ANV with videoangiography was possible in 36 subfoveal CNV membranes (61%). In four cases it was possible to recognize two nutrition vessels, and in one 3 ANV were identified in the same CNV. A R (racquet) pattern was found in 18 CNV (50%), in one case with two ANV and in another ARCH SOC ESP OFTALMOL 2006; 81: 79-84 81

YOUSSFI-RICH A, et al. case with three. In 16 cases (45.5%) an umbrella pattern was described, one of which had two ANV. In two eyes both patterns were identified in the same membrane (5.4%). The mean length of the main trunk was 127 SD 88 microns, with extreme values of 100 and 290 microns, while the mean diameter was 83.3 SD 43.3 microns with a range between 20 and 150 microns. The main ANV was extrafoveal (XF) in 12 cases (33.3%), juxtafoveal (JF) in 14 cases (38.9%), and subfoveal (SF) in 10 cases (27.8%). It was most frequently found nasal vis-à-vis the macula, (11 cases), followed by temporal in 6 cases, upper halffield in 4 and lower half-field in 5. Particularly, the racquet pattern was localized in 11 cases as being XF, in five JF and in four SF. The capacity to detect ANVs with visual acuity is seen in table I, the ARMD type in table II, the lesion size in table III and the evolution time in table IV. DISCUSSION The studied population exhibits the typical characteristics found in an ARMD population. In addition, the findings of AGF are compatible with the results of a recently published study (7). The identification of the ANV was heralded in 1991 by the Macular Photocoagulation Study Group (MPS) which recommended focal photocoagulation thereof, if visible, in relapsing retro-foveal of juxtafoveal CNVs (6). However, the identification of said ANV, in subfoveal CNV, presents important difficulties mainly due to the low visibility of said vessels within the neovascular mesh and because they are visible for a very short period of the angiogram (1-4 seconds). In 1998, due to the high-speed, high resolution angiography by means of confocal scan laser, the first results were published about the identification of Table I. Correlation between the identification of an afferent nutrition vessel (ANV) and visual acuity (VA) VA Without ANV With ANV total 0.36 8 14 > 0.1 and < 0.36 13 19 0.1 11 15 26 2336 59 Mann-Whitney Test, p=0.861. Table II. Correlation between the identification of an afferent nutrition vessel (ANV) and the type of neovascular complex (CNV): classic, mixed, hidden with fibrovascular detachment (OC1) and hidden with belated ooze of non-determined origin (OD2) CNV Without VNA With VNA Total Classic 35 8 Mixed 1 5 6 OC1 1319 32 OC2 6 7 13 Total 2336 59 Fisher's exact test, p=0.265. Table III. Correlation between the identification of an afferent nutrition vessel (ANV) and the size of the neovascular complex (CNV) CNV size Without vessels With vessels Total <5 mm 2 8 4 12 >5 and <15 mm 2 6 17 23 >15 mm 2 9 15 24 Total 2336 59 Mann-Whitney Test, p=0.267. ANV and its selective photocoagulation as a treatment for sub-foveal CNV in ARMD (4). It is surprising to find such a low number of studies and the variability of their data in what concerns the identification of ANVs in ARMD. In our work, where hidden membranes predominate (45 of 59 eye), the identification of said vessels by means of dynamic ICG with HRT has been achieved in 61% of the 59 eyes with MCNV secondary to ARMD. Said results are in contrast with those supplied by other authors in literature because they are remarkably higher than those found by Shiraga, who was able to identify ANV in 22%, 37 patients out of a population of 170 patients with Table IV. Correlation between the identification of an afferent nutrition vessel (ANV) and the evolution time Evolution Without ANV With ANV Total < 6 m 8 21 29 >6 m and < 12 m 6 6 12 > 12 m 9 9 18 Total 2336 59 Mann-Whitney Test, p=0.09. 82 ARCH SOC ESP OFTALMOL 2006; 81: 79-84

Diagnóstico de vasos nutricios de complejos neovasculares subfoveales coroideos subfoveal membrane CNV (27 with classic membrane and 10 hidden) (4). In addition, Piermarocchi obtained very similar results identifying ANV in 35 (22.4%) out of 156 eyes with predominantly classic subfoveal MCNV (8). On the other hand, a pilot study by Staurenghi detected ANV in 19 of 22 classic subfoveal CNV membranes (86%) (5), while Glaser visualized ANV in over 75% of hidden CNVs (data presented in Course 308 of the American Ophthalmology Academy, Dallas, Texas, November 2000). All these data are higher than those of this study. The explanation for this discrepancy can be due to several facts, firstly to the evolution time (which is not mentioned in other studies). In the patients of our series we have found a tendency to a better visualization of ANVs if the evolution time was under 6 months (p<0.099). With lower evolution times, the neovascular mesh is less dense and therefore it is easier to find the ANV. This has also been described by Piermarocchi who demonstrated how he detected 84.2% of ANVs in 112 eyes after treatment with dynamic phototherapy. This produces a rarefaction of the coriocapillary, as demonstrated by Flower (9), associated to a localized reduction of vascular flow, producing a reduction of the angiographic noise inside and around the coroidal membrane, thus facilitating the identification of said vessels. Secondly, said differences can be due to the type of membrane (classic or hidden). Even though statistically significant differences have not been found, the visualization of said vessels is somewhat higher in classic membranes (10 cases out of 14 patients) and in hidden membranes with fibrovascular detachment (19 of 32 cases). Finally, the higher prevalence of detection in our work with regard to that found by Shiraga or Piermarocchi can also be explained by a possible slant in the diagnostic criteria for the ANV. Said authors have only assessed vessels with the main trunk in the same plane of the neovascular complex. If we restrict the search to the racquet pattern (which is more likely to be photocoagulated), in our results the existence of ANVs is reduced to 30% of patients. The detection of ANV is not enough; it must be photocoagulated and therefore being placed preferably extrafoveal or at least juxtafoveal, over 300 microns from the fovea. Thus, the cases selected for treatment in our group were reduced to 16 patients ARCH SOC ESP OFTALMOL 2006; 81: 79-84 (25,4%). In the reduced group of five patients we utilized the Staurenghi criteria, who considered cases for treatment those with ANV diameters under 85 microns, i.e., five(8,4%). It is not surprising that four of these patients had an evolution under 6 months. The following factors did not prove either a statistically significant association with the presence of ANV: patient age, visual acuity or size of the lesion. From the results of this study it can be concluded that ANV was identified in 61% of a population with clearly or vaguely limited CNVs, and in 24.5% of cases said vessel was extra- or juxtafoveal and therefore susceptible to treatment with laser. REFERENCES 1. Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn Ha, et al. The Framingham Eye Study monograph: Ann ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2361 adults, 1973-1975. Surv Ophthalmol 1980; 24: 335-610. 2. Barbazetto I, Burdan A, Bressler NM, Bressler SB, Haynes L, et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--tap and VIP report No. 2. Arch Ophthalmol 2003; 121: 1253-1268. 3. Eckardt C, Eckardt U, Conrad HG. Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1999; 237: 313-325. 4. Shiraga F, Ojima Y, Matsuo T, Takasu I, Matsuo N. Feeder vessel photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology 1998; 105: 662-669. 5. Staurenghi G, Orzalesi N, La Capria A, Aschero M. Laser treatment of feeder vessels in subfoveal choroidal neovascular membranes: a revisitation using dynamic indocyanine green angiography. Ophthalmology 1998; 105: 2297-2305. 6. Subfoveal neovascular lesions of age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group. Arch Ophthalmol 1991; 109: 1242-1257. 7. Torrón Fernández-Blanco C, Melcon Sánchez-Friera B, Ferrer Novella E, Ruiz Moreno O, Honrubia López FM. Angiografía con verde de indocianina y neovascularización subretiniana. Patrones en la degeneración macular asociada a la edad. Arch Soc Esp Oftalmol 2001; 76: 226-228. 8. Piermarocchi S, Lo Giudice G, Sartore M, Friede F, Segato T, Pilotto E, et al. Photodynamic therapy increases the 83

YOUSSFI-RICH A, et al. eligibility for feeder vessel treatment of choroidal neovascularization caused by age-related macular degeneration. Am J Ophthalmol 2002; 133: 572-575. 9. Flower RW, von Kerczek C, Zhu L, Ernest A, Eggleton C, Topoleski LD. Theoretical investigation of the role of choriocapillaris blood flow in treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration. Am J Ophthalmol 2001; 132: 85-93. 84 ARCH SOC ESP OFTALMOL 2006; 81: 79-84